Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 0 | 300 | 0 | 0 | 0 |
| Gross Profit | N/A | 300 | N/A | N/A | N/A |
| Operating Expenses | 94,585 | 65,241 | 66,992 | 55,417 | 42,619 |
| Operating Income | -94,585 | -64,941 | -66,992 | -55,417 | -42,619 |
| Other Income | -77 | -15,819 | -21,443 | 1,780 | 760 |
| Pre-tax Income | -94,662 | -80,760 | -88,435 | -53,637 | -41,859 |
| Income Tax | -3 | 142 | -160 | -302 | 156 |
| Net Income Continuous | -94,659 | -80,902 | -88,275 | -53,335 | -42,015 |
| Net Income | $-94,659 | $-80,902 | $-88,275 | $-53,335 | $-42,015 |
| EPS Basic Total Ops | -7.14 | -7.70 | -30.30 | -30.16 | -33.60 |
| EPS Basic Continuous Ops | -7.14 | -7.70 | -30.30 | -30.17 | -33.68 |
| EPS Diluted Total Ops | -7.14 | -7.70 | -30.30 | -30.16 | -33.60 |
| EPS Diluted Continuous Ops | -7.14 | -7.70 | -30.30 | -30.17 | -33.68 |
| EPS Diluted Before Non-Recurring Items | -7.14 | -7.70 | -19.52 | -30.00 | -33.60 |
| EBITDA(a) | $-94,280 | $-64,703 | $-66,909 | $-55,306 | $-42,361 |